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Abstract
Background: Autism is a common heritable neurodevelopmental disorder with complex etiology. Several genome-wide
linkage and association scans have been carried out to identify regions harboring genes related to autism or autism
spectrum disorders, with mixed results. Given the overlap in autism features with genetic abnormalities known to be
associated with imprinting, one possible reason for lack of consistency would be the influence of parent-of-origin effects
that may mask the ability to detect linkage and association.
Methods and Findings: We have performed a genome-wide linkage scan that accounts for potential parent-of-origin
effects using 16,311 SNPs among families from the Autism Genetic Resource Exchange (AGRE) and the National Institute of
Mental Health (NIMH) autism repository. We report parametric (GH, Genehunter) and allele-sharing linkage (Aspex) results
using a broad spectrum disorder case definition. Paternal-origin genome-wide statistically significant linkage was observed
on chromosomes 4 (LODGH = 3.79, empirical p,0.005 and LODAspex = 2.96, p = 0.008), 15 (LODGH = 3.09, empirical p,0.005
and LODAspex = 3.62, empirical p = 0.003) and 20 (LODGH = 3.36, empirical p,0.005 and LODAspex = 3.38, empirical p = 0.006).
Conclusions: These regions may harbor imprinted sites associated with the development of autism and offer fruitful
domains for molecular investigation into the role of epigenetic mechanisms in autism.
Citation: Fradin D, Cheslack-Postava K, Ladd-Acosta C, Newschaffer C, Chakravarti A, et al. (2010) Parent-Of-Origin Effects in Autism Identified through Genome-
Wide Linkage Analysis of 16,000 SNPs. PLoS ONE 5(9): e12513. doi:10.1371/journal.pone.0012513
Editor: Marie-Pierre Dube´, Universite de Montreal, Canada
Received March 15, 2010; Accepted August 4, 2010; Published September 2, 2010
Copyright:  2010 Fradin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partially funded by NIH 2P50HG003233 and CDC 5U01DD000183. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript. The collection of data and biomaterials that participated in the National Institute of Mental Health (NIMH)
Autism Genetics Initiative has been supported by National Institute of Health grants MH52708, MH39437, MH00219 and MH00980; National Health Medical
Research Council grant 0034328; and by grants from the Scottish Rite, the Spunk Fund, Inc., the Rebecca and Solomon Baker Fund, the APEX Foundation, the
National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD), and the endowment fund of the Nancy Pritzker Laboratory (Stanford); and by
gifts from the Autism Society of America, the Janet M. Grace Pervasive Developmental Disorders Fund, and families and friends of individuals with autism. The
collection data and biomaterials also come from the Autism Genetic Resource Exchange (AGRE) collection. This program has been supported by a National
Institutes of Health grant MH64547 and the Cure Autism Now Foundation.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dfallin@jhsph.edu
Introduction
Autism is a neurodevelopmental disorder that is manifested in
early childhood and is characterized by impairments in reciprocal
social interactions and language, and a restricted range of
behaviors and interests. Autism is considered a spectrum disorder
(ASD) with heterogeneity in symptom presentation. Inheritance
clearly plays a major role in susceptibility to autism
[1,2,3,4,5](OMIM %209850), yet efforts to identify susceptibility
genes have been complicated by the apparent heterogeneous and
complex etiology of this disorder. While some important genetic
discoveries have been made (reviewed in [6]), much of the
heritable variation in autism remains unexplained.
Epigenetic factors, which are often heritable, yet not part of the
DNA sequence, are one element which may contribute to this
etiologic complexity. Imprinting is an epigenetic modification that
is parental origin specific, leading to preferential expression of a
specific parental allele in somatic cells of the offspring [7].
Mechanisms such as DNA methylation, RNA-associated silencing
and histone modification cause relative silencing of a specific
parental allele. The vital role of imprinted genes in mammalian
prenatal growth and development is shown most clearly by the
abnormal development and early demise of embryos that inherit
two copies of either a maternal or paternal genome, rather than
the usual one of each [8]. In addition, the fact that many known
imprinted genes are expressed in the brain (reviewed in [8])
suggests that such genes could play a role in autism, which is
believed to have underpinnings in neuroanatomic differences that
arise prenatally [9,10]. The genetic disorders Prader-Willi and
Angelman syndromes, which result from defects in imprinting or
the loss of expression of imprinted genes in the chromosomal
region 15q11-q13 [11] are associated with autistic features and
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diagnoses [12,13,14,15,16], and maternally transmitted abnor-
malities of chromosome 15 have been detected in autistic patients
[12,17,18].
If imprinting plays a role in the heritable etiology of ASD, the
power of linkage analyses to identify susceptibility loci may be
improved by accounting for allelic parent-of-origin. This has been
observed for specific autism-implicated genomic regions such as
7q, where both paternal and maternal allele sharing have been
observed to account for the linkage to an autism locus in this
region [19]–[20]. In a follow-up of previous linkage findings, Liu
et al. reported partitioning of IBD sharing per parent on
chromosomes 5, 16, 18 and 19, with both maternal and paternal
peaks observed on chromosomes 5 and 19, suggesting the presence
of multiple loci with parent-of-origin effects [21]. Arking et al.
identified linkage and association with the CNTNAP2 gene
(contactin-associated protein-like 2) using genome-wide SNP
analyses [22]. Further characterization of this signal showed
maternal-specific parent-of-origin effects among heterozygotes.
To date, however, no genome-scale parent-of-origin-specific
linkage analysis has been reported for ASD. Here we apply parent-
of-origin linkage analysis to the genome-wide SNP data recently
reported by Weiss et al. in a common set of multiplex autism
families [23].
Methods
Subjects
The samples used here were previously described by Weiss et al.
[23]. Nine hundred ninety three (993) families (896 affected sibling
pairs) from the AGRE (Autism Genetic Resource Exchange)
sample and 223 families (174 affected sibling pairs) from the
NIMH (National Institute of Mental Health) Autism Genetics
Initiative were included. AGRE families with a child diagnosed
with an Autism Spectrum Disorder (ASD) based on evaluation by
the Autism Diagnostic Interview-Revised (ADI-R) [24] were
recruited from across the US. Further information on participant
recruitment and study procedures has been described elsewhere
[25] and is available on the program website (www.agre.org).
From AGRE, we considered children with autism, ‘‘not quite
autism (NQA),’’ or ‘‘broad spectrum’’ as affected family members
to encompass those with related disorders such as Aspergers
syndrome and PDD-NOS. Information on participant recruitment
and study procedures for the NIMH sample is available on the
program website (www.nimh.nih.gov). We selected NIMH families
with a child diagnosed with an Autism Spectrum Disorder based
on evaluation by the Autism Diagnostic Interview-Revised (ADI-
R) and ADOS instruments. The combined data set, consisting of
1,216 nuclear families, was used for genetic analyses. All families
used in our analyses had at least one genotyped parent; 89.4% had
genotypes for both parents.
All samples used in this study arose from investigations
approved by the appropriate Institutional Review Boards for
institutions where participants were recruited, evaluated, or where
genotype data were generated. Written informed consent was
obtained for all adult study participants; for children under age 18,
both the consent of the parents or guardians and the assent of the
child were obtained. This secondary analysis of de-identified data
was considered to be exempt from IRB review.
Markers
SNP genotyping was previously described [23]. The AGRE
samples were genotyped on Affymetrix 5.0 chips at the Genetic
Analysis Platform of the Broad Institute, using standard protocols.
The NIMH autism samples were genotyped at the Johns Hopkins
Center for Complex Disease on the Affymetrix 500K (Nsp and
Sty) and 5.0 platforms using similar standard protocols. We
selected an extremely high quality set of SNPs for linkage analysis,
including only SNPs genotyped in both data sets with 99.5%
concordance and #1 Mendelian error. Linkage analysis involving
high densities of markers, where clusters of markers are in linkage
disequilibrium (LD), can lead to biased results [26]. To alleviate
these concerns, we analyzed a pruned set of 16,311 highly
polymorphic, high-quality autosomal SNPs that did not contain
any two nearby markers correlated with r2 .0.1, providing a
marker density of 0.25 cM. Genetic distances were taken from the
Affymetrix Genetic Map (www.affymetrix.com/estore/browse/
products.jsp?productId = 131459&categoryId = 35906#1_3)[26].
Linkage analyses and simulations
Parametric and non-parametric parent-of-origin linkage meth-
ods were applied. Parametric linkage analysis was conducted using
GENEHUNTER-IMPRINTING 2.1 (GHI) [27], with 1216
informative families. Using GHI, for each chromosome, we began
with a fully penetrant maternal or paternal model with no
phenocopies. Allele frequencies were estimated using the founders,
and LOD scores under heterogeneity (HLOD) were calculated at
five equally spaced intervals between markers. For each suggestive
linkage result (HLOD$2 for either maternal or paternal models),
additional models were fit allowing for reduced penetrance or
increased phenocopy rates to assess the sensitivity of the linkage
signal to alternative parameters using the following procedure. We
began by reducing the parent-specific penetrance at increments of
0.2 (i.e., penetrances of 1, 0.8, 0.6, 0.4, 0.2) and by increasing
phenocopy rates at similar increments. Empirical p values for these
sensitivity results were estimated similarly to the initial genome-
wide empirical p values (see below), but with the optimized
parametric model applied for all locations.
For non-parametric linkage analysis, maximum likelihood
estimates of allele sharing at each locus were computed using
the ASPEX ‘‘sib_ibd’’ command. The ‘‘sex_split’’ option was
implemented to evaluate evidence for linkage based on maternal
and paternal sharing separately. 1070 affected sibling pairs were
informative (had $1 parental genotype) for these analyses. LOD
scores indicate the log ratio of the likelihood of the marker data at
this position with the MLE estimate of the sibling recurrence risk
ratio, versus the likelihood assuming a sibling risk ratio of 1.
Empirical genome-wide p values were calculated via simulation.
The program Merlin [28,29] was used to generate replicates of
families identical to those in our sample with respect to marker
informativeness, spacing and missing data patterns, and with
affection status preserved but no relationship between simulated
genotypes and affection. Merlin assigned random genomes to
founders according to allele frequencies at each marker, then
passed chromosomes through the pedigree using the relationships
specified in the original pedigree file and recombination fractions
specified by our genetic map. Linkage analyses were then
performed on these unlinked replicates and genome-wide
empirical p values were estimated by extrapolating results for
chromosome 1 to the whole-genome level, assuming chromosome
1 represents 0.1 of the genome. Empirical genome-wide p values
reported here were based on 2,000 replicates.
Results and Discussion
Genome-wide results for maternal and paternal linkage analyses
via both parametric and non-parametric methods are shown in
Figure 1. The highest HLOD and LOD signals on each
chromosome are shown in Table 1. The final models for the
Parent-of-Origin in Autism
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strongest linkage signals from sensitivity analyses of parametric
models are shown in Table 2. Paternal peaks based on both
parametric and allele-sharing analyses were observed on chromo-
somes 4 (rs6826933:rs17088473, HLOD=3.79, p,0.005;
LOD=2.96, p= 0.008; Table 1, Figures 1, 2), 15 (rs11855650:
rs10520676, HLOD=3.09, p,0.005; LOD=3.62, p= 0.003;
Table 1, Figures 1, 2) and 20 (rs16999397:rs200888, HLOD=3.36,
p,0.005; LOD=3.38, p= 0.006; Table 1, Figures 1, 2). All p
values reported reflect genome-wide testing based on simulation.
Additional paternal peaks with HLODs .2 were observed on
chromosomes 1, 6, 10, and 17 in the parametric analyses, with
empirical genome-wide p values #0.01 (Table 1).
Although significant maternal peaks were observed in both
parametric and allele-sharing methods, no consistency in signal
was seen. A significant maternal peak was observed on
chromosome 14 in parametric analyses (rs923485:rs17177789,
HLOD =2.38, p = 0.01), although this was not observed in allele-
sharing analysis. Maternal allele sharing peaks were observed on
chromosomes 5, 6, 7, and 9 (Table 1), although these were not
seen in parametric models.
Given the vital role of imprinted genes in development, the fact
that many known imprinted genes are expressed in the brain, and
evidence of overlapping features in autism and imprinting
disorders, we investigated the effect of incorporating allelic
parent-of-origin into an autosomal linkage scan for autism. To
our knowledge, this is the most extensive linkage analysis for
parent-of-origin effects in autism to date. We found the strongest
evidence for parent-of-origin effects on chromosomes 4, 20 and 15,
implicating sites where imprinted loci related to autism may reside.
The section of chromosome 4 located between markers
rs6826933 and rs17088473 showed several significant results in
our analysis and spans the region between 4q12-4q13.2. Recently,
Weiss et al. found an association between one SNP (rs17088254,
p = 8.561026) located on this region and autism using the same
data without regard to parental origin. The strongest candidate
gene in this region is CLOCK, which codes a protein regulating
circadian rhythm and whose involvement in ASD was first
proposed by Wimpory et al. [30]. The most consistent results
reporting abnormal circadian rhythms in ASD concern the
melatonin synthesis pathway. At least five independent groups
detected abnormal melatonin levels in ASD [31,32,33,34]. Several
lines of evidence suggest that melatonin could modulate neuronal
networks by influencing both the strength and the circadian
oscillation of neuronal transmission [35,36].
Analyses of a panel of microsatellite markers in 348 AGRE
families from previously reported linkage analysis[21,37] also
showed paternal allele sharing on chromosome 4 (Figure S1).
However, the peak using the microsatellite panel was 29cM away
from the SNP peak (D4S1591:GATA30B11, LODpat = 2.96,
p = 0.008). The location of this microsatellite peak also showed
linkage in the SNP data, but it was not the highest SNP linkage
peak on chromosome 4.
A region of chromosome 15 (15q23-15q25.3) also shows
paternal linkage. This region was previously implicated using
traditional linkage analysis in these SNP data [23], though it this
was not the strongest linkage signal in that analysis. A genome-
wide assessment of structural abnormalities in 427 unrelated ASD
cases found a microdeletion of 4,289,500bp on 15q23-q24.2
Figure 1. Results of Genome-wide Linkage Analysis. Panel A: Parametric results. Panel B: Allele sharing results. Maternal scores are shown in
red; paternal scores are in blue; no-imprinting scores are shown in gray.
doi:10.1371/journal.pone.0012513.g001
Parent-of-Origin in Autism
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12513
associated with ASD [38]. This region includes the RASGRF1
gene, a homologue of the imprinted rasgrf1 in mouse [8]. The
protein encoded by this gene is a guanine nucleotide exchange
factor (GEF). Functional analysis has demonstrated that this
protein stimulates the dissociation of GDP from RAS protein.
Studies of the similar gene in mice suggested that the Ras-GEF
activity of this protein in the brain can be activated by Ca2+
influx, muscarinic receptors, and G protein beta-gamma subunit.
Mouse studies also indicated that the Ras-GEF signaling pathway
mediated by this protein may be important for long-term memory.
Others genes in this region with plausible connections to autism
risk include NRG4 (neuregulin 4) and CHRNA3/B4 (cholinergic
receptor, nicotinic). Genes in the neuregulin[39] and cholinergic
families[40] have already been implicated in autism risk. The
15q23-q25.3 region also encompasses the MTHFS (5,10-methe-
nyltetrahydrofolate synthetase) gene which is implicated in DNA
methylation cycle and may be particularly important in an
epigenetic mechanism of autism risk.
We have also reported a strong paternal linkage on chromo-
some 20p, which was previously implicated in the linkage analyses
reported by Weiss et al[23]. In analyses of these data without
consideration of parent-of-origin, this region achieved a LOD
score in excess of 2.0. According our results using the same data
set, this linkage is supported by paternal transmission. Deletions of
Table 1. Highest Linkage Peaks Per Chromosome.
Parametric (GHI) Allele-Sharing (Aspex)
Chr Map (cM) No-imp HLOD Pat. HLOD Mat. HLOD Pval** Map (cM) No-imp LOD Pat. LOD Mat. LOD Pval**
1 156.55 0.66 2.38 0 0.01 168.67 0.76 1.52 20.76 0.17
164.99 2.54 (1A)* 0.01
2 82.90 0.43 0.12 1.00 1.00 15.77 0.85 20.66 1.52 0.21
3 189.11 1.03 0 1.64 0.22 192.74 1.67 20.1 1.79 0.13
4 67.85 2.55 0.01 74.81 2.01 2.96 20.95 0.008
67.85 1.99 3.79 (4A) 0 ,0.005 123.65 3.13 2.45 0.68 0.02
5 182.85 0.49 1.85 0 0.08 205.55 1.82 20.42 2.24 0.05
6 177.24 3.46 2.59 1.01 0.01 188.29 3.87 1.15 2.72 0.02
175.93 2.72 (6A) 0.01
7 20.32 0.55 0 1.79 0.13 156.43 2.99 0.84 2.16 0.06
8 NA ,1 ,1 ,1 NA 120.57 1.952 0.63 1.29 0.31
9 158.19 0.73 0 1.44 0.76 156.77 2.00 20.31 2.32 0.04
10 169.29 0.72 2.69 0 0.01 103.52 2.22 0.36 1.86 0.12
11 111.01 0.77 1.13 0 1.00 114.49 1.40 1.87 20.48 0.08
12 134.99 0.30 0 1.19 1.00 29.46 0.80 1.14 20.34 0.23
13 56.98 0.86 0.02 1.04 1.00 113.79 2.75 2.05 0.71 0.06
14 62.33 0.43 0 2.38 0.01 18.67 0.58 1.15 20.56 0.37
15 79.68 1.78 2.59 0.03 0.01 92.16 3.52 3.62 20.11 0.003
64.61 3.09 (15A) ,0.005
16 121.30 0 1.16 0 1.00 78.81 1.41 1.77 20.35 0.10
17 45.23 2.15 2.03 0.58 0.01 81.45 1.56 2.02 20.46 0.07
18 NA ,1 ,1 ,1 NA 91.97 1.33 1.27 0.06 0.3
19 92.91 0.16 1.27 0 0.92 37.73 2.75 0.99 1.77 0.13
20 3.38 3.04 3.24 0.83 ,0.005 3.20 4.13 3.38 0.75 0.006
0.40 3.36 (20A) ,0.005
21 3.58 0.66 0.28 1.55 0.58 6.12 1.23 0.17 1.06 0.45
22 NA ,1 ,1 ,1 NA 2.25 0.60 20.75 1.35 0.28
*Optimal parametric model for this linkage signal (see Table 2).
**Empirical genome-wide p values based on 5000 simulations.
doi:10.1371/journal.pone.0012513.t001
Table 2. Optimized Parametric Models.
Model P(+/+)* P(d/+) P(+/d) P(d/d)
Primary models paternal 0.001 0.999 0.001 0.999
maternal 0.001 0.001 0.999 0.999
Optimal models** 1A 0.001 0.499 0.001 0.499
4A 0.001 0.399 0.099 0.499
6A 0.001 0.599 0.199 0.799
15A 0.001 0.499 0.001 0.499
20A 0.001 0.799 0.199 0.999
*Paternally inherited allele named first. +: wild-type allele; d: disease allele; P:
penetrance.
**Parameter values for best linkage signal after exploratory sensitivity analysis.
doi:10.1371/journal.pone.0012513.t002
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the 20pter region have been reported in two distinct autism cases
[41,42]. The first patient presented an interstitial deletion in
20p11.22-p11.23 whereas the second, a 3-year-old boy with a
moderate to severe mental retardation and autistic behavior
patterns, carried a deletion at 20pter-p12.2. Moreover, this linked
region encompasses the SNPH (Syntaphiliyn) gene. SNPH
interacts with the synaptic vesicle-associated protein synaptobre-
vin/VAMP and the plasma membrane-associated protein
SNAP25 to form the SNARE complex, which is required for
synaptic vesicle docking and fusion. Expression of this gene
appears to be brain specific.
Other suggestive parent-specific linkage regions are located
throughout the genome (on chromosomes 1, 5, 6, 7, 8, 9, 10, 13,
14, 17 and 21). The paternally linked region on chromosome 1
(1q23-1q24.2) was previously associated with autism. Wassink et al
report a male child with autism having a maternal uniparental
disomy (UPD) of chromosome 1 [43]. Moreover, in a previous
genome wide linkage analysis, Bartlett et al. also found a linkage
between the 1q23-1q24 region and autism using an AGRE sample
[44].
A maternally linked region was observed on chromosome 5,
with the peak at 5p13.1. Recent genome-wide association studies
have reported risk loci for autism at 5p14.1 [45,46]. The
Imprinted Gene Database (www.geneimprint.com) lists four
predicted imprinted genes on chromosome 5; however the regions
do not directly overlap the location detected by our analysis.
The signal found on 6q25.3-6q27 region was previously linked
to autism [23,47,48]. Recently, Glessner et al. found that PARK2
gene located on 6q25.2-6q27 was significantly enriched for CNVs
and observed in the ASD cases only [49]. They identified a
deletion of about 3 kb in PARK2 allele inherited from father.
PARK2 is an ubiquitin-protein ligase, mutations of which cause
autosomal recessive juvenile Parkinson’s disease [50]. Moreover,
several autism cases with subtle interstitial deletions in the q24-q26
region of the long arm of chromosome 6 have been reported [51].
Some imprinted genes have also been described in this 6q region
like the SLC22A (solute carrier family 22) genes.
Two other groups have previously reported parent-of-origin
linkage with autism for closely located loci on chromosome 7; one
was a paternal contribution in the region 7q31.33-7q34 [19], the
other showed a paternally derived locus more proximally located
on 7q22.1-7q22.2 and a maternally derived locus on 7q32.1-
7q32.2 [20]. In our analysis, the strongest chromosome 7 signal
was at 156.43 cM on nearby 7q35 under the maternal model.
While not our strongest parent-of-origin signal, this provides
further support for the presence of a maternally expressed locus in
this region. Indeed, this region encompasses the CNTNAP2 gene, a
member of the neurexin superfamily, that is significantly
associated with autism susceptibility [22,52,53,54], and has shown
maternal transmission of risk [22].
Few previous studies have considered parent-or-origin effects in
autism. Those that have used previous-generation marker sets and
much smaller samples than the results presented here. Two
previous studies observed parent-or-origin linkage on chromosome
7, but with different regions and types of parental sharing [19,20].
We did not reach genome-wide significant evidence for maternal
or paternal transmission on chromosome 7, although a non-
significant maternal linkage is observed in a region overlapping the
Lamb et al report. The regions identified in our analysis were not
covered in previous parent-of-origin analyses, to our knowledge,
with the exception of chromosome 15, where the Lamb et al did
not see paternal sharing, but examined only a small number of
sibling pairs and with few microsatellite markers.
In an attempt to detect loci with possible parent-of-origin
effects, we used multiple statistical approaches, rather than relying
on a single strategy. Consistent evidence of linkage across multiple
methods increases support for a true linkage. However, the
appropriate interpretation of inconsistent results across parametric
and non-parametric analyses is not entirely clear. These may be
due to chance findings in one analysis, or they may be true linkage
that only one method was sufficiently powered to detect. For
example, the chromosome 1 peak was significant only in the
parametric analysis, a method which is more powerful given that
the parameters are correctly specified. While it is unrealistic to
believe that we could actually have specified the ‘‘correct’’
parameters given the complex nature of autism, those selected
may have been sufficiently close. Peaks on chromosomes 6 and 9
were significant in the non-parametric ASPEX analysis; however,
the parametric GHI analysis did not find significant peaks on these
chromosomes, which may be due to selection of ‘‘incorrect’’
parameters for the models run.
These analyses considered as affected all children with an ASD,
as defined by the ADI-R and ADOS in the NIMH sample.
However, in AGRE, we included those with autistic disorder, as
well as those with ‘‘not quite autism’’ and ‘‘broad spectrum’’ to
encompass Asperger’s and PDD-NOS. This may have contributed
to some heterogeneity or misclassification in our data, but was
considered more appropriately inclusive and comparable to the
NIMH ASD families than excluding a larger number of AGRE
families with an ASD other than autistic disorder.
Our results suggest the usefulness of genome-wide analysis with
evaluation of parent-of-origin effects, although future studies are
necessary to determine if these results can be replicated. Given the
potential role for imprinting and other epigenetic mechanisms in
neuropsychiatric disorders such as autism [55], the regions
identified are good candidates for assessment of functional variants
and their relationship to epigenetic marks such as methylation
status on paternal and maternal DNA. These results could provide
completely novel insight into the biology and pathogenesis of a
common neurodevelopmental disorder.
Supporting Information
Figure S1 Parent-of-Origin Linkage Analysis for Microsatellite
Markers in 384 AGRE families. A: Parametric results. Panel B:
Allele sharing results. Maternal scores are shown in red; paternal
scores are in blue.
Found at: doi:10.1371/journal.pone.0012513.s001 (0.68 MB TIF)
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